CTOs on the Move

Renovia Incorporated

www.renoviainc.com

 
Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia`s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women`s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Renovia Incorporated raised $17M on 04/19/2021

Similar Companies

DuVal and Associates PA

DuVal and Associates PA is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Optogenics Of Syracuse Inc

Optogenics Of Syracuse Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Equipment Collaborative

Equipment Collaborative is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brijjitco

The Brijjit™ technology is created and produced by BrijjitCo, a limited liability company based in Atlanta, GA.. Our founder and CEO, Felmont (Monte) F. Eaves, III, MD, FACS, is a highly credentialed plastic surgeon who saw a gap and was determined to bridge it. No, we`re not a huge company. Yet. But we are singularly focused on improving the surgical landscape with breakthrough technologies that will support surgeons everywhere in their goal to deliver the most spectacular outcomes. We strongly believe that Brijjit™ is just such an innovation, and we don`t plan to stop there!

Astellas Gene Therapies

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.